SARS CoV 2 News and Research

RSS

Molnupiravir does not induce resistance mutations in SARS-CoV-2 genome

A new study has pointed out that Molnupiravir treatment increases the ratio of transition to transversion mutations in COVID-19 patients and that the treatment does not appear to induce resistance mutations in the SARS-CoV-2 genome.

19 Jul 2022

Researchers discover new key protection against COVID-19 in saliva

The novel coronavirus (SARS-CoV-2) has spread around the world at an unprecedented rate, evading containment countermeasures.

19 Jul 2022

What is the impact of SARS-CoV-2 variant booster vaccinations?

Researchers conducted preliminary assessments of a booster vaccination with the SARS-CoV-2 variant vaccines.

19 Jul 2022

The known and proposed interactions of SARS-CoV and SARS-CoV-2 with DNA damage response pathways

Researchers reviewed the consequences of infection with sSARS-CoVs on the host DNA damage response.

19 Jul 2022

Influence of chr12q24.13 domain on COVID-19 severity

Researchers evaluated the probable impact of the chr12q24.13 domain on the outcomes of laboratory-validated SARS-CoV-2 infection.

19 Jul 2022

Scientists explore guanine-specific pocket in SARS-CoV-2 nucleocapsid protein of therapeutic value against multiple coronaviruses

Researchers studied open and closed conformations of the C-terminal of SARS-CoV-2 nucleocapsid (N) protein termed the NCTD.

19 Jul 2022

What were the drivers of influenza decline during the COVID-19 pandemic?

Researchers investigated the potential drivers of a global decline in influenza virus circulation during the COVID-19 pandemic.

19 Jul 2022

What is the efficacy of the second, third, and fourth dose of the COVID-19 mRNA vaccine?

Investigators examined the effectiveness of two, three, and four SARS-CoV-2 vaccine doses during the Omicron prevalent phases.

19 Jul 2022

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

A new study involving hospitalized women in six African countries from the University of Maryland School of Medicine's (UMSOM) Institute of Human Virology (IHV) showed that pregnant women with SARS-CoV-2, the virus that causes COVID-19, had double the risk of being admitted to the intensive care unit (ICU) and four-times the risk of dying in-hospital than pregnant women who did not have COVID-19.

19 Jul 2022

Should siRNA-based antivirals be added to the COVID toolbox?

A recent study reviewed the existing treatment modalities, including vaccines and antivirals, for SARS-CoV-2 infection.

19 Jul 2022

Research describes one of the ways the SARS-CoV-2 virus recruits cells to replicate

An article published in the journal Frontiers in Cellular and Infection Microbiology reports a study by researchers at the State University of Campinas (UNICAMP) and the University of São Paulo (USP) in Brazil showing how a human protein interacts with a SARS-CoV-2 protein, and describing one of the ways the virus that causes COVID-19 recruits cells to replicate.

18 Jul 2022

Reducing barriers to access provincial COVID-19 vaccination data in Canada

Roadblocks to accessing data on vaccine effectiveness from provincial health ministries impede researchers' ability to inform a national pandemic response and maintain public trust, according to an analysis in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.211712.

18 Jul 2022

SARS CoV 2 News and Research

Molnupiravir does not induce resistance mutations in SARS-CoV-2 genome

Researchers discover new key protection against COVID-19 in saliva

What is the impact of SARS-CoV-2 variant booster vaccinations?

The known and proposed interactions of SARS-CoV and SARS-CoV-2 with DNA damage response pathways

Influence of chr12q24.13 domain on COVID-19 severity

Scientists explore guanine-specific pocket in SARS-CoV-2 nucleocapsid protein of therapeutic value against multiple coronaviruses

What were the drivers of influenza decline during the COVID-19 pandemic?

What is the efficacy of the second, third, and fourth dose of the COVID-19 mRNA vaccine?

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

Should siRNA-based antivirals be added to the COVID toolbox?

Research describes one of the ways the SARS-CoV-2 virus recruits cells to replicate

Reducing barriers to access provincial COVID-19 vaccination data in Canada

Decline in mental health during pregnancy throughout the COVID-19 lockdown period

Study quantifies the likelihood of future COVID-19 following natural infection or vaccination

What is the impact of lower COVID-19 vaccine doses in younger cohorts?

Analyzing whether SARS-CoV-2 nucleocapsid and spike proteins stimulate dendritic or γδ T cells

Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

How effective is previous infection in preventing reinfection with Omicron BA.4/BA.5?

The pathobiology, host response, and effects of SARS-CoV-2 on the respiratory and intestinal microbiome

Study suggests COVID-19 vaccination may be associated with short-term changes in usual menstrual cycle length

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News